ImportantArrangements for strategic, technical, manufacturing, or marketing tie up
Gland Pharma partnered with a global pharma company for a full-service CDMO agreement to manufacture sterile injectable products.
Gland Pharma LimitedGLAND · Filed with the exchange
This collaboration covers 55 SKUs across three sites, with expected annual revenue potential of USD 90-100 million starting 2029, boosting long-term visibility.
No comments yet. Be the first.